Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Choosing between radiation therapy and surgery for prostate cancer isn't just about survival — it's about what side effects you're willing to live with. A large propensity-matched study found that radiation carries higher risks of bladder and urinary inflammation, while surgery is more strongly linked to incontinence and erectile dysfunction. Experts say these differences should drive personalized, patient-centered treatment conversations.
When it comes to treating prostate cancer, the two most common definitive options — radiation therapy (RT) and radical prostatectomy (RP) — aren't interchangeable. A new study presented at the American College of Surgeons annual meeting compared over 10,000 propensity-matched patients in each group and found that each treatment comes with its own distinct set of long-term risks.
Radiation therapy was associated with higher all-cause mortality and greater risks of cystitis, hematuria, and prostatitis. Surgery, on the other hand, carried significantly higher risks of urinary incontinence, erectile dysfunction, urinary tract infections, and urinary obstruction. The findings underscore that no single treatment is universally "better" — it depends on the patient's priorities and health profile.
By the Numbers:
Why it matters: These findings give clinicians and patients a clearer, data-backed picture of what each treatment path actually looks like over time — helping move prostate cancer care toward more individualized, informed decision-making.
